482
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Novel markers, a payer's perspective: Commissioning a new service

&
Pages 103-108 | Published online: 01 Jun 2010

Figures & data

Figure 1. An outline of the hierarchy of evidence that will be required before (first six tiers) and following the implementation of a new test (audit of impact).

Figure 1. An outline of the hierarchy of evidence that will be required before (first six tiers) and following the implementation of a new test (audit of impact).

Figure 2. To show the relationship between the commissioning cycle (the central panel) and the steps involved in generating the evidence to address a clinical need or policy problem (the outer, shaded panels).

Figure 2. To show the relationship between the commissioning cycle (the central panel) and the steps involved in generating the evidence to address a clinical need or policy problem (the outer, shaded panels).

Figure 3. An outline of the relationship between the commiss ioners, purchasers and providers. The commissioners in the primary care trust will work with general practitioners (primary care physicians) to identify the clinical needs of the local population (possibly with practice based commissioners), and then determine where the care will be delivered. The pathology commissioning network will work with the commissioners to determine the specification of the laboratory medicine (pathology) service required to meet the need identified. The shaded boxes denote the elements of the organisation involved in funding the provision of health care.

Figure 3. An outline of the relationship between the commiss ioners, purchasers and providers. The commissioners in the primary care trust will work with general practitioners (primary care physicians) to identify the clinical needs of the local population (possibly with practice based commissioners), and then determine where the care will be delivered. The pathology commissioning network will work with the commissioners to determine the specification of the laboratory medicine (pathology) service required to meet the need identified. The shaded boxes denote the elements of the organisation involved in funding the provision of health care.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.